Neuropsychiatric Immune-Related Adverse Events Induced by Pembrolizumab in a Patient With Lung Adenocarcinoma and Systemic Lupus Erythematosus

Internal Medicine - Japan
doi 10.2169/internalmedicine.3782-19

Related search